Default company panoramic image

Flyberry Capital

Exceptional MIT PhDs, focused on decoding massive data streams to identify, and profit from, major events.

  • Stage Full Product Ready
  • Industry Financial Services
  • Location Mid-Cambridge, Cambridge, MA, USA
  • Currency USD
  • Founded March 2011
  • Employees 10
  • Website

Company Summary

In today’s markets, institutional investors are unable to extract meaningful insights from growing volumes of data. When major events occur, response time is paralyzed when the stakes are highest. Flyberry Capital is made up of truly exceptional MIT PhDs, building models to rapidly decode streaming data in an automated fashion. Our tools can be customized to allow funds to profit from big events, or manage major shocks with ease.


  • Default avatar
    Michael Chang

    Technology Architecture, Investment design & risk control
    - Conceived and built event-based arbitrage models, and end-to-end investment process that showed 200% returns over 3 months.
    - PhD in Electronic Engineering and Computer Science from MIT.
    - Research work led to the successful formation of two MIT spin-offs.
    - Recipient of 4 High Impact Journal covers within 3 years, including a Nature Cover, accounting for 1/4 of all department cover

  • Default avatar
    Aone Wang

    Operations and Business Development
    - Director of BD in charge of $400M revenue business operations for Foxconn (2001-2011).
    - 10 years of experience in BD and operations as part of a Global Fortune 100 company.
    - Experience in Global Market Operations within the US, EU, Asia, Mexico and Brazil, with a
    CAGR of 30% over the past 6 years of operation.
    - MS Industrial & System Engineering from Georgia Institute of Technology.

  • Default avatar
    Zeid Barakat

    Corporate Strategy and Business Development
    - Co-Founder of PointCare Inc., a growing care service site. Early Co-founder of Aura Biosciences (recently raised $5M).
    - Former Sr. Manager with PRTM (acquired by PwC). Worked with Fortune-500 firms; led major strategic initiatives, e.g. M&A events, global expansions.
    - Previous Associate Dir. at Altus Pharma. Led a successful $50M series B prior to IPO.
    - MIT Sloan MBA; Harvard MA (Biotechnology)

  • Default avatar
    Sean Chang

    Lead Framework Developer in Information Arbitrage Systems
    - PhD Electronic Engineering and Computer Science from MIT.
    - Google US/Canada PhD Fellowship in Human-Computer Interaction 2011.
    - Best Student Paper Award, ACM UIST 2009
    - Bronze Medal, International Olympia in Informatics (IOI) 2000.
    - 50,000+ hours of programming experience.


  • Default avatar
    Foley & Lardner
    Default avatar
    Bonanno, Savino & Davies, P.C.